Abstract
The alcoholic hepatitis syndrome is a disease that is relatively easy to define for groups of patients. It is much more difficult to define for individual patients. This acute disorder of the liver is characterized by a history of excessive alcohol intake, by jaundice and hepatomegaly, and by laboratory abnormalities that include increased serum aminotransferase and alkaline phosphatase activity and leukocytosis composed largely of neutrophils. Prolongation of prothrombin time is common. Fever, ascites, and splenomegaly are often present. Abdnominal pain and anorexia occur frequently.
Long quaffing maketh a short lyfe. John Lyly
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rankin JGD, Orrego-Matte H, Deschenes J, et al: Alcoholic liver disease: The problem of diagnosis. Alcoholism: Clin Exp Res 2:327–328, 1978.
Kryger S, Schlichting O, Dietrichson O, et al: The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis. Scand J Gastroenterol 18:691–696, 1983.
Poynard T, Degott C, Munoz C, et al: Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension. Dig Dis Sci 32:337–343, 1987.
Helman RA, Temko SS, Nye SW, et al: Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med 74:311–321, 1987.
Conn HO, Blei AT, Chojkier M, et al: The naked physician: The blind interpretation of liver function tests in the differential diagnosis of jaundice, in Preisig R, Bircher J (eds): The Liver: Quantitative Aspects of Structure and Function. Third International Gstaad Symposium, Gstaad, 1978, pp. 386–394.
Morris JS, Gallo GA, Scheuer PJ, et al: Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology 68:750–754, 1975.
Morgan MY, Sherlock S: Sex-related differences among 100 patients with alcoholic liver disease. Br Med J 1:939–941, 1977.
Orrego H, Blendis LM, Crossley IR, et al: Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat. Gastroenterology 80:546–556, 1981.
Skrainka B, Stahlhut J, Fulbeck CL, et al: Measuring liver span. Bedside examination versus ultrasound and scintiscan. J Clin Gastroenterol 8:267–270, 1986.
Espinoza P, Ducot B, Pelletier G, et al: Interobserver agreement in the physical diagnosis of alcoholic liver disease. Dig Dis Sci 32:244–247, 1987.
Rasmussen SN: Liver volume by ultrasonic scanning. Br J Radiol 45:579, 1972.
Weiss JS, Gautam A, Lauff JJ, et al: The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. S Engl J Med 309:147–150, 1983.
Sanchez-Tapias JM, Fiol B, Rodes J: (+)-Cyanidanol-3 in mild alcoholic hepatitis, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 173–175.
Palmas S: Treatment of alcoholic cirrhosis with (+)-Cyanidanol-3, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 167–171.
Zimmerman HJ, Seeff LB: Enzymes in hepatic disease, in Coodley EL (ed): Diagnostic Enzymology. Philadelphia, Lea & Febiger, 1970, pp. 1–38.
Cohen JA, Kaplan MM: The SGOT/SGPT Ratio—An indicator of alcoholic liver disease. Dig Dis Sci 24:835–838, 1979.
Nalpas B, Vassault A, Charpin S, et al: Serum mitochondrial asparate aminotransferase as a marker of chronic alcoholism: Diagnostic value and interpretation in a liver unit. Hepatology 6:608–614, 1986.
Orrego H, Kalant H, Israel Y, et al: Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease. Gastroenterology 76:105–115, 1979.
Maddrey WC, Boitnott JK, Bedine MS, et al: Adrenocosteroid therapy of alcoholic hepatitis. Gastroenterology 75:193–199, 1978.
Maddrey WC, Carithers JR RL, Herlong HF, et al: Prednisolone therapy in patients with severe alcoholic hepatitis. Results of a multicenter trial. Hepatology 6:1202, 1986 (abst).
Conn HO: The management of alcoholic hepatitis, in Conn HO (ed): International Workshop on (+)-Cyanidanol-3 in Diseases of the Liver. Royal Society of Medicine, Academic Press, London and Grune and Stratton, New York, 1981, pp. 147–156.
Hallak A, Conn HO: Prognostic value of blood tests in alcoholic hepatitis (AH). Analysis of the randomized clinical trials (RCT). (in preparation)
Porter HP, Simon FR, Pope CE, et al: Corticosteroid therapy in severe alcoholic hepatitis: A double-blind drug trial. S Engl J Med 284:1350–1355, 1971.
Campra JL, Hamlin EM, Kirshbaum RJ, et al: Prednisone therapy of acute alcoholic hepatitis: Report of a controlled trial. Ann Intern Med 79:625–631, 1973.
Blitzer BL, Mutchnick MG, Joshi PH, et al: Adrenocorticosteroid therapy in alcoholic hepatitis: A prospective, double-blind randomized study. Am J Dig Dis 22:477–484, 1977.
Lesesne HR, Bozymski EM, Fallon HJ: Treatment of alcoholic hepatitis with encephalopathy: Comparison of prednisolone with caloric supplements. Gastroenterology 74:169–173, 1978.
Shumaker JB, Resnick RH, Galambos JT, et al: A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. Am J Gastroenterol 69:443–449, 1978.
Depew W, Boyer T, Omata M, et al: Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 78:524–529, 1980.
Mendenhall CL, Anderson S, Garcia-Pont P, et al: Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. S Engl J Med 23:1464–1470, 1984.
The Copenhagen Study Group for Liver Diseases: Testosterone treatment of men with alcoholic cirrhosis. A double-blind study. Hepatology 6:807–813, 1986.
Nasrallah SM, Galambos JT: Aminoacid therapy of alcoholic hepatitis. Lancet 2:1276–1277, 1980.
Diehl AM, Boitnott JK, Herlong F, et al: Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 5:57–63, 1985.
Baker AL, Jaspan JB, Haines NW, et al: A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: Progress report in 50 patients. Gastroenterology 80:1410–1414, 1981.
Halle P, Pare P, Kaptein E, et al: Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis. Gastroenterology 82:925–931, 1982.
Resnick RH, Boitnott J, Iber FL, et al: Preliminary observations of d-penicillamine therapy in acute alcoholic liver disease. Digestion 11:257–265, 1974.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
Conn, H.O., Hallak, R. (1989). Alcoholic Hepatitis Syndrome: Prognosis and Course. In: Seeff, L.B., Lewis, J.H. (eds) Current Perspectives in Hepatology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7041-3_18
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7041-3_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7043-7
Online ISBN: 978-1-4684-7041-3
eBook Packages: Springer Book Archive